ROTFLMAO You're comparing apples and oranges. The six month statement includes two months of Vitacig results and only one month of Omni/Malecon results. To make things clearer for investors, the 2FQ17 10-Q also contains a pro-forma statement that shows the results as if the acquisition had taken place as of May 1, 2016 and only included Omni results...
Malecon/Omni actually had $1,626,687 in real revenue from operations during 1FQ17 and $1,619,113 in net income for the first six months. The fact that $1 million of the income came from discontinued operations is in conformance with GAAP accounting rules and was properly reported and available for all investors to see in each quarterly financial report. The gain came from the return of VTCQ/OMHE stock by mCig in exchange for the VitaCig product line. You gave the following link but conveniently left out the fact that Omni specifically pointed out that $1 million in net profit was from discontinued operations, leaving $500,000 in operational income. There was no deception...
Operational net income has been adversely affected by costs involved in Omni becoming a public company. These one time costs should be alleviated in upcoming quarters and as revenues increase.
Too little accounting knowledge can be a dangerous thing